You may also like
CAPACITY-COVID: a European Registry to Determine the Role of Cardiovascular Disease in the COVID-19 Pandemic
To accelerate knowledge on the role of cardiovascular disease in the COVID-19 pandemic, standardized and coordinated data collection on a large scale is of pivotal importance.
Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial
Implementation of a KDIGO-derived treatment bundle is feasible in a multinational setting. Furthermore, moderate to severe AKI was significantly reduced in the intervention group.
Initial Experience with del Nido Cardioplegia Solution at a Pediatric and Congenital Cardiac Surgery Program in Brazil
In our congenital cardiac surgery population, del Nido cardioplegia strategy was associated with less ventricular dysfunction with LCOS, a lower VIS and decreased ICU LOS compared with patients that received our standard myocardial protection using a modified St. Thomas’ solution. Despite the limitation of this study, including its retrospective nature and cohort size, these data supported our transition to incorporate del Nido cardioplegia solution with a mandatory reperfusion period as the preferred myocardial protection method in our program.
